Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance

Rifampin is one of the most important biofilm-active antibiotics in the treatment of periprosthetic joint infection (PJI), and antibiotic regimens not involving rifampin were shown to have higher failure rates. Therefore, an emerging rifampin resistance can have a devastating effect on the outcome o...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwich, Ali, Dally, Franz-Joseph, Bdeir, Mohamad, Kehr, Katharina, Miethke, Thomas, Hetjens, Svetlana, Gravius, Sascha, Assaf, Elio, Mohs, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469909/
https://www.ncbi.nlm.nih.gov/pubmed/34572721
http://dx.doi.org/10.3390/antibiotics10091139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469909/
https://www.ncbi.nlm.nih.gov/pubmed/34572721
http://dx.doi.org/10.3390/antibiotics10091139

Ejemplares similares